Basket | Login | Register

 
 
 
 

Cost of illness and burden of dementia in Europe - Prognosis to 2030

Cost of dementia

by Anders Wimo, MD, PhD, Professor, Karolinska Institutet, Linus Jönsson, PhD, I3 Innovus and Anders Gustavsson, Senior Analyst, I3 Innovus

Prognosis to 2030

This prognosis of costs is only based on a prevalence prognosis, based on UN´s demographic forecast combined with Eurocode´s new prevalence figures for Europe (figure 1).

Figure 1. Prognosis for the number of demented in Europe until 2030.

Figure 1. Prognosis for the number of demented in Europe until 2030.

As seen in figure 1, the number of demented will increase considerably from about 10 million today to about 14 million demented persons in 2030.

The cost prognosis is seen in Figure 2. The costs are rather similar in Northern, Western and Southern Europe while costs are considerably lower in Estern Europe (where most people with dementia live). The demographic forecast of costs will result in an increase in the whole Europe by about 43% between 2008 and 2030 to over 250 billions €.

Figure 2. Prognosis for the future costs of dementia in Europe until 2030

Figure 2: Prognosis for the future costs of dementia in Europe until 2030

References

  1. Jönsson L, Wimo A. Economic burden of Alzheimer’s Disease in Europe. A review of evidence and methodological considerations . Pharmacoeconomics (in press)
  2. SBU. Dementia. A systematic review. Stockholm: Staten beredning för medicinsk utvärdering (SBU) (The Swedish Council on Technology Assessment in Health Care) 2008. Report No.: 172E/1-3.
  3. Wimo, A., L. Jönsson, et al. (2008). The cost of illness and burden of dementia in Europe. Dementia in Europe Yearbook 2008. A. Europe. Luxembourg, Alzheimer Europe : 67-71.
  4. Hofman A, Rocca WA, Brayne C, Breteler MM, Clarke M, Cooper B, et al. The prevalence of dementia in Europe: a collaborative study of 1980-1990 findings. Eurodem Prevalence Research Group. Int J Epidemiol. 1991 Sep;20(3):736-48.
  5. Ferri, C. P., M. Prince, et al. (2005). "Global prevalence of dementia: a Delphi consensus study." Lancet 366 (9503): 2112-7.
  6. SBU (2008). Dementia. A systematic review. Stockholm, Staten beredning för medicinsk utvärdering (SBU) (The Swedish Council on Technology Assessment in Health Care).
  7. Lobo, A., L. J. Launer, et al. (2000). "Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group." Neurology 54 (11 Suppl 5): S4-9.
  8. UN. (1998). "World population prospects: The 1998 revision. World population 1950-2050." 1998.
  9. Word Economic Outlook. (http://www.imf.org/external/pubs/ft/weo/2008/02/weodata/weorept.aspx?sy=2006&ey=2008&scsm=1&ssd=1&sort=country&ds=%2C&br=1&c=163%2C998&s=PPPPC&grp=1&a=1&pr.x=6&pr.y=6. )
  10. Eurostat.(http://epp.eurostat.ec.europa.eu/tgm/table.do?tab=table&language=en&pcode=cp060&tableSelection=1&footnotes=yes&labeling=labels&plugin=1).
  11. Word Economic Outlook. (http://www.imf.org/external/pubs/ft/weo/2008/02/weodata/weorept.aspx?sy=2005&ey=2008&scsm=1&ssd=1&sort=country&ds=%2C&br=1&c=914%2C962%2C913%2C921%2C963%2C960%2C922%2C942%2C926&s=PCPI&grp=0&a=&pr1.x=42&pr1.y=7)
  12. Kronborg Andersen C, Sogaard J, Hansen E, Kragh-Sorensen A, Hastrup L, Andersen J, et al. The cost of dementia in Denmark: the Odense Study. Dement Geriatr Cogn Disord. 1999;10(4):295-304.
  13. O'Shea E, O'Reilly S. The economic and social cost of dementia in Ireland. Int J Geriatr Psychiatry. 2000;15(3):208-18.
  14. Jonsson L, Eriksdotter Jonhagen M, Kilander L, Soininen H, Hallikainen M, Waldemar G, et al. Determinants of costs of care for patients with Alzheimer's disease. Int J Geriatr Psychiatry. 2006 May;21(5):449-59.
  15. Wimo A, Johansson L, Jönsson L. Demenssjukdomarnas samhällskostnader och antalet dementa i Sverige 2005 (The societal costs of dementia and the number of demented in Sweden 2005) (in Swedish). Stockholm: Socialstyrelsen; 2007. Report No.: 2007-123-32 .
  16. Knapp M, Prince M. Dementia UK. London: Alzheimer’s Society; 2007 Contract No.: Document Number|.
  17. Scuvee-Moreau J, Kurz X, Dresse A. The economic impact of dementia in Belgium: results of the National Dementia Economic Study (NADES). Acta Neurol Belg. 2002 Sep;102(3):104-13..
  18. Rigaud AS, Fagnani F, Bayle C, Latour F, Traykov L, Forette F. Patients with Alzheimer's disease living at home in France: costs and consequences of the disease. J Geriatr Psychiatry Neurol. 2003 Sep;16(3):140-5.
  19. Schulenberg J, Schulenberg I. Cost of treatment and cost of care for Alzheimer´s disease in Germany. In: Wimo A, Jonsson B, Karlsson G, Winblad B, editors. The Health Economics of dementia. London: John Wiley & Sons.; 1998. p. 217-30.
  20. Koopmanschap MA, Polder JJ, Meerding WJ, Bonneux L, van der Maas PJ. Costs of dementia in the Netherlands. In: Wimo A, Jonsson B, Karlsson G, Winblad B, editors. The Health Economics of dementia. London: John Wiley & Sons.; 1998. p. 207-16.
  21. Cavallo MC, Fattore G. The economic and social burden of Alzheimer disease on families in the Lombardy region of Italy. Alzheimer Dis Assoc Disord. 1997;11(4):184-90.
  22. Trabucchi M. An economic perspective on Alzheimer's disease. J Geriatr Psychiatry Neurol. 1999;12(1):29-38.
  23. Boada M, Pena-Casanova J, Bermejo F, Guillen F, Hart WM, Espinosa C, et al. [Costs of health care resources of ambulatory-care patients diagnosed with Alzheimer's disease in Spain]. Med Clin (Barc). 1999 Nov 27;113(18):690-5.
  24. Zencir M, Kuzu N, Beser NG, Ergin A, Catak B, Sahiner T. Cost of Alzheimer's disease in a developing country setting. Int J Geriatr Psychiatry. 2005 Jul;20(7):616-22
  25. Gulacsi, L., K. Karpati, et al. (2008). Disease burden of dementia in Hungary, a 154 patient cross-sectional survey 2008 Budapest, Corvinus University.

 

 
 

Last Updated: mardi 27 octobre 2009

 

 
 

Options

  • Send this page to a friend